An Update on FDA's New GMP Initiatives and PAT for Drugs
Abstract: From the Southeast ASQ FDC/FDA Conference in Raleight (January, 2004).
Already a member? Access this Content
You will need Adobe Reader to view this PDF document.
Download the free Reader from Adobe
You must log in to comment. Please log in or register. Comments FAQ
